| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,240 |
9,419 |
$293K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,828 |
7,395 |
$289K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,919 |
1,873 |
$152K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,646 |
1,598 |
$127K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,735 |
2,486 |
$91K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
499 |
477 |
$73K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
343 |
332 |
$72K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,112 |
1,072 |
$57K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,820 |
1,651 |
$40K |
| 99381 |
|
469 |
464 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
474 |
448 |
$33K |
| 87634 |
|
493 |
463 |
$27K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
275 |
275 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
498 |
474 |
$22K |
| 95117 |
|
1,797 |
639 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,206 |
1,142 |
$14K |
| 0001A |
|
1,027 |
971 |
$12K |
| 95115 |
|
1,613 |
600 |
$12K |
| 0002A |
|
844 |
808 |
$10K |
| 92567 |
|
871 |
821 |
$10K |
| 99215 |
Prolong outpt/office vis |
145 |
139 |
$9K |
| 99205 |
Prolong outpt/office vis |
115 |
92 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
479 |
420 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
504 |
422 |
$6K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
459 |
451 |
$5K |
| 87631 |
|
43 |
39 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
444 |
391 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
98 |
36 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
14 |
14 |
$3K |
| 17110 |
|
44 |
40 |
$3K |
| 0071A |
|
78 |
72 |
$3K |
| 90461 |
|
1,313 |
1,236 |
$3K |
| 0003A |
|
222 |
214 |
$3K |
| 99490 |
Ccm add 20min |
865 |
860 |
$2K |
| 0072A |
|
58 |
58 |
$2K |
| 69210 |
|
54 |
49 |
$2K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
12 |
12 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
30 |
30 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$855.34 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$491.15 |
| 87807 |
|
28 |
28 |
$286.00 |
| 90677 |
|
728 |
715 |
$241.49 |
| 0124A |
|
17 |
17 |
$120.00 |
| 81002 |
|
44 |
39 |
$100.74 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
40 |
39 |
$98.61 |
| 0004A |
|
18 |
17 |
$78.00 |
| 83037 |
|
15 |
13 |
$73.44 |
| 90682 |
|
27 |
27 |
$43.63 |
| 99441 |
|
29 |
28 |
$34.34 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
27 |
$7.84 |
| 90697 |
|
481 |
471 |
$0.26 |
| 4274F |
|
43 |
43 |
$0.19 |
| 91300 |
|
12 |
12 |
$0.07 |
| 91307 |
|
33 |
33 |
$0.03 |
| 90686 |
|
74 |
74 |
$0.02 |
| 1160F |
|
2,419 |
2,175 |
$0.00 |
| 3078F |
|
1,719 |
1,582 |
$0.00 |
| 1159F |
|
1,929 |
1,764 |
$0.00 |
| 90681 |
|
413 |
411 |
$0.00 |
| 90633 |
|
89 |
87 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
286 |
271 |
$0.00 |
| 90710 |
|
29 |
29 |
$0.00 |
| 3288F |
|
31 |
25 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
79 |
76 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
13 |
13 |
$0.00 |
| 90648 |
|
36 |
36 |
$0.00 |
| 90662 |
|
35 |
35 |
$0.00 |
| 3077F |
|
38 |
36 |
$0.00 |
| 3725F |
|
18 |
18 |
$0.00 |
| 90756 |
|
32 |
32 |
$0.00 |
| 90713 |
|
21 |
21 |
$0.00 |
| 90700 |
|
23 |
23 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
931 |
825 |
$0.00 |
| 1126F |
|
6,124 |
5,743 |
$0.00 |
| 3074F |
|
2,605 |
2,386 |
$0.00 |
| 2010F |
|
1,307 |
1,192 |
$0.00 |
| 3079F |
|
588 |
553 |
$0.00 |
| 1125F |
|
2,417 |
2,232 |
$0.00 |
| 3008F |
|
6,541 |
6,003 |
$0.00 |
| 2000F |
|
3,686 |
3,378 |
$0.00 |
| 1036F |
|
9,469 |
8,701 |
$0.00 |
| 3037F |
|
745 |
680 |
$0.00 |
| 1035F |
|
79 |
76 |
$0.00 |
| 1034F |
|
63 |
54 |
$0.00 |
| 4010F |
|
126 |
118 |
$0.00 |
| 90698 |
|
231 |
230 |
$0.00 |
| 2001F |
|
256 |
225 |
$0.00 |
| 99439 |
|
38 |
38 |
$0.00 |
| 3044F |
|
24 |
24 |
$0.00 |
| 3075F |
|
45 |
44 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
171 |
122 |
$0.00 |
| 90744 |
|
66 |
66 |
$0.00 |
| 36416 |
|
13 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
15 |
$0.00 |
| 1101F |
|
18 |
12 |
$0.00 |
| 90680 |
|
39 |
38 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
19 |
13 |
$0.00 |
| 1170F |
|
31 |
25 |
$0.00 |
| 1006F |
|
16 |
16 |
$0.00 |